Guest guest Posted December 25, 2010 Report Posted December 25, 2010 Pharmaceutical companies are always whining not enough people enroll in clinical trials. However, they erect numerous barriers to getting into trials. First of all, and most important to me, they insist upon CT scans. Patients such as me who have been in multiple clinical trials are tired of being irradiated to death. MRIs provide equivalent information on tumor size. That's been my experience when I've had them. Drug companies like CT scans better for one reason, and one reason only; they're cheaper. Damn the patient, full-speed ahead. Patients are only units to be quanitified anyway. Travel expenses: For my last clinical trial (flavopiridol) I had to pay out-of-pocket for flights to and from San Diego, as well as taxi costs and hotel stays. I was so sick after each treatment, especially with terrible and uncontrollable diarrhea that I could not fly home that day. This is a trial of 28 visits. It cost me over $10,000 to do the whole trial, and this was not reimbursed by anyone. I am not rich and that wiped me out. Exclusions: If you've had another cancer, even several years ago, you are not eligible. If you have had other therapies, you're sometimes not eligible. If you haven't had fludarabine, many times you're not eligible. Etc. etc. Drug companies want to have it all; the compliant patients, the cheap process, excellent results. I understand that the FDA is one major culprit, as Dr. Keating has written, they want more and more data every year, ratcheting up the cost to ever higher and higher levels. But the drug companies share a lot of the blame as well. One thing interests the drug companies. The bottom line. That's it. Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.